Taken together, it is worthwhile to evaluate the effect of TRI-BE and other triazaspiranes on other signaling pathways (for example, JAK-STAT3 and PI3K/Akt) and establish their potential effect as molecules that regulate tumor progression. This evidence concerns the gene AKT1 and neoplasm.